The study authors gathered data on individual HIV viral load trajectories at the population-level following the introduction of universal test and treat in sub-Saharan Africa.
To help clinicians and patients determine if antibodies protect against reinfection, the ACP discussed tests for diagnosing and estimating the prevalence of COVID-19.
Researchers conducted testing during a nursing home outbreak where paired respiratory specimens were collected to assess performance of the BinaxNOW antigen test compared to virus culture and RT-PCR.
Investigators adapted a simple compartmental epidemic model to simulate SARS-CoV-2 spread, death, and associated costs in the US in an effort to understand the role of at home testing.
Researchers examined mammography and colonoscopy rates among commercially insured US adults before and after the declaration of the COVID-19 public health emergency to assess changes in screening.
Using artificial intelligence algorithm techniques, the system identifies regions of interest during colonoscopy, which can help clinicians determine whether further assessment is needed.
Researchers examined correlations between SAT, IMAT, and pectoralis PM areas from chest CT with mortality in individuals with COPD.
Researchers systematically reviewed literature to understand the performance and sensitivity of alternative sample types compared with that of nasopharyngeal swabs for the diagnosis of SARS-CoV-2.
The io instrument processes a single-use cartridge that contains all reagents for testing collected vaginal swabs and male urine samples.
Researchers conducted a cross-sectional study among HCP at 4 large health care systems in 3 US states to assess the risk factors associated with SARS-CoV-2 seropositivity.
